Sandra Jesus

Coimbra, 3000548, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Unraveling the Potential of Giardia Extracellular Vesicles as a Vaccine Candidate.

Unraveling the Potential of Giardia Extracellular Vesicles as a Vaccine Candidate.

Journal: Pharmaceutics

Published: February 19, 2026

Yeast-Derived Glucan Particles: Biocompatibility, Efficacy, and Immunomodulatory Potential as Adjuvants and Delivery Systems.

Yeast-Derived Glucan Particles: Biocompatibility, Efficacy, and Immunomodulatory Potential as Adjuvants and Delivery Systems.

Journal: Pharmaceutics

Published: July 17, 2025

Exploring the immunomodulatory properties of glucan particles in human primary cells.

Exploring the immunomodulatory properties of glucan particles in human primary cells.

Journal: International journal of pharmaceutics

Published: November 15, 2023

Endotoxin contamination of nanoparticle formulations: A concern in vaccine adjuvant mechanistic studies.

Endotoxin contamination of nanoparticle formulations: A concern in vaccine adjuvant mechanistic studies.

Journal: Vaccine

Published: January 07, 2023

Unravelling the Immunotoxicity of Polycaprolactone Nanoparticles-Effects of Polymer Molecular Weight, Hydrolysis, and Blends.

Unravelling the Immunotoxicity of Polycaprolactone Nanoparticles-Effects of Polymer Molecular Weight, Hydrolysis, and Blends.

Journal: Chemical research in toxicology

Published: October 14, 2020

Chitosan-coated PLGA nanoparticles for the nasal delivery of ropinirole hydrochloride: In vitro and ex vivo evaluation of efficacy and safety.

Chitosan-coated PLGA nanoparticles for the nasal delivery of ropinirole hydrochloride: In vitro and ex vivo evaluation of efficacy and safety.

Journal: International journal of pharmaceutics

Published: April 16, 2020

Safe-by-Design of Glucan Nanoparticles: Size Matters When Assessing the Immunotoxicity.

Safe-by-Design of Glucan Nanoparticles: Size Matters When Assessing the Immunotoxicity.

Journal: Chemical research in toxicology

Published: March 07, 2020

Chitosan Nanoparticles: Shedding Light on Immunotoxicity and Hemocompatibility.

Chitosan Nanoparticles: Shedding Light on Immunotoxicity and Hemocompatibility.

Journal: Frontiers in bioengineering and biotechnology

Published: October 31, 2019

A Methodological Safe-by-Design Approach for the Development of Nanomedicines.

A Methodological Safe-by-Design Approach for the Development of Nanomedicines.

Journal: Frontiers in bioengineering and biotechnology

Published: October 31, 2019

Hazard Assessment of Polymeric Nanobiomaterials for Drug Delivery: What Can We Learn From Literature So Far.

Hazard Assessment of Polymeric Nanobiomaterials for Drug Delivery: What Can We Learn From Literature So Far.

Journal: Frontiers in bioengineering and biotechnology

Published: August 02, 2019

Poly(D,L-Lactic Acid) Nanoparticle Size Reduction Increases Its Immunotoxicity.

Poly(D,L-Lactic Acid) Nanoparticle Size Reduction Increases Its Immunotoxicity.

Journal: Frontiers in bioengineering and biotechnology

Published: March 27, 2019

Chitosan Plus Compound 48/80: Formulation and Preliminary Evaluation as a Hepatitis B Vaccine Adjuvant.

Chitosan Plus Compound 48/80: Formulation and Preliminary Evaluation as a Hepatitis B Vaccine Adjuvant.

Journal: Pharmaceutics

Published: December 22, 2018

Showing 1-12 of 22

Last Updated: 09/26/2026